Gloria Melanie

Insider profile

Performance

Overall performance
1.8

Performance over holding periods
1.8
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Gloria Melanie's trades of Immunovant Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-22 2026-05-20 S Sale
75,622 -32.0%
283.45
US$2,421,677
75,622 -32.0% 283.45 US$2,421,677
2026-05-22 2026-05-20 S Sale
49,247 -24.5%
426.24
US$757,254
49,247 -24.5% 426.24 US$757,254
2026-05-22 2026-05-20 S Sale
59,519 +47.6%
225.11
US$4,740,749
59,519 +47.6% 225.11 US$4,740,749
2026-04-10 2026-04-08 S Sale
8,722 -3.4%
24.83
US$216,567
8,722 -3.4% 24.83 US$216,567
2026-04-10 2026-04-08 S Sale
8,722 -3.4%
24.83
US$216,567
8,722 -3.4% 24.83 US$216,567
2026-02-27 2026-02-25 S Sale
942 -0.6%
28.90
US$27,224
942 -0.6% 28.90 US$27,224
2026-02-27 2026-02-25 S Sale
859 -0.5%
28.16
US$24,189
859 -0.5% 28.16 US$24,189
2026-02-27 2026-02-25 S Sale
1,437 -0.8%
26.98
US$38,770
1,437 -0.8% 26.98 US$38,770
2025-11-21 2025-11-20 S Sale
2,375 -1.4%
23.97
US$56,929
2,375 -1.4% 23.97 US$56,929
2025-11-21 2025-11-20 S Sale
10,251 -5.5%
23.54
US$241,309
10,251 -5.5% 23.54 US$241,309